home / stock / nuvb / nuvb news


NUVB News and Press, Nuvation Bio Inc. Class A From 07/21/21

Stock Information

Company Name: Nuvation Bio Inc. Class A
Stock Symbol: NUVB
Market: NYSE
Website: nuvationbio.com

Menu

NUVB NUVB Quote NUVB Short NUVB News NUVB Articles NUVB Message Board
Get NUVB Alerts

News, Short Squeeze, Breakout and More Instantly...

NUVB - Notable earnings after Thursday's close

[[ABCB]], [[ASB]], [[BOOM]], [[CE]], [[COF]], [[CSL]], [[EIG]], [[FE]], [[FFBC]], [[FFIN]], [[GBCI]], [[HTH]], [[INTC]], [[NUVB]], [[OZK]], [[RHI]] ,[[RNR]], [[SAM]],[[SIVB]], [[SKX]], [[SNAP]] ,[[TWTR]] ,[[VICR]], [[VRSN]],[[WRB]], [[WSFS]]For Seeking Alpha's full earnings season c...

NUVB - Shares of Nuvation Bio Inc. Class A (NUVB) Fall to a New 52-Week Low

Nuvation Bio Inc. Class A (NYSE:NUVB) traded at a new 52-week low today of $8.15. Approximately 116,000 shares have changed hands today, as compared to an average 30-day volume of 1 million shares. In the past 52 weeks, Nuvation Bio Inc. Class A share prices are bracketed by a current lo...

NUVB - Nuvation Bio Inc. Class A: The Losing Streak Continues (NUVB)

Nuvation Bio Inc. Class A (NYSE:NUVB) traded at a new 52-week low today of $8.43. This new low was reached on below average trading volume as 133,000 shares traded hands, while the average 30-day volume is approximately 1.1 million shares. In the past 52 weeks, shares of Nuvation Bio Inc...

NUVB - Tracking David Abrams' Abrams Capital Management Portfolio - Q1 2021 Update

David Abrams’ 13F portfolio value increased ~25% this quarter from $3.55B to $4.44B. The number of positions decreased from 17 to 16. Abrams Capital Management added Change Healthcare while dropping TransMedics Group during the quarter. The top three positions are Lithia Mo...

NUVB - Nuvation Bio Appoints David C. Hanley, Ph.D., as Chief Technical Operations Officer

Nuvation Bio Appoints David C. Hanley, Ph.D., as Chief Technical Operations Officer Experienced technical operations and CMC leader brings scientific and strategic expertise in oncology drug development and life cycle management PR Newswire NEW YORK , J...

NUVB - Nuvation Bio Inc. Class A: The Winning Streak Continues (NUVB)

Shares of Nuvation Bio Inc. Class A (NYSE:NUVB) traded today at $15.23, eclipsing its 52-week high. So far today approximately 164,000 shares have been exchanged, as compared to an average 30-day volume of 443,000 shares. Over the past year, Nuvation Bio Inc. Class A has traded in a rang...

NUVB - Nuvation Bio to Participate in the Jefferies Virtual Healthcare Conference

Nuvation Bio to Participate in the Jefferies Virtual Healthcare Conference PR Newswire NEW YORK , May 26, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differen...

NUVB - Tracking Seth Klarman's Baupost Group Holdings - Q1 2021 Update

Seth Klarman’s 13F portfolio value increased from $10.84B to $12.56B this quarter. Baupost Group increased Alphabet and Intel while reducing Fox Corp and dropping ViacomCBS. They also built small stakes in several SPACs. The portfolio continues to be heavily concentrated wi...

NUVB - Nuvation Bio reports Q1 results

Nuvation Bio (NUVB): Q1 GAAP EPS of -$0.12.Cash, cash equivalents and marketable securities of $824.7MPress Release For further details see: Nuvation Bio reports Q1 results

NUVB - Nuvation Bio Reports First Quarter 2021 Financial Results and Provides Business Update

Nuvation Bio Reports First Quarter 2021 Financial Results and Provides Business Update Ongoing enrollment in Phase 1/2 study of NUV-422 in high-grade gliomas Strong balance sheet with cash, cash equivalents and marketable securities of $824.7million as of March 31, 2021 ...

Previous 10 Next 10